Insulet Current Ratio 2007-2019 | PODD

Current and historical current ratio for Insulet (PODD) from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Insulet current ratio for the three months ending June 30, 2019 was 4.72.
Insulet Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.50B $0.11B 4.72
2019-03-31 $0.50B $0.11B 4.36
2018-12-31 $0.46B $0.12B 3.99
2018-09-30 $0.45B $0.10B 4.58
2018-06-30 $0.42B $0.08B 5.54
2018-03-31 $0.45B $0.08B 5.48
2017-12-31 $0.54B $0.09B 6.24
2017-09-30 $0.37B $0.08B 4.88
2017-06-30 $0.34B $0.05B 7.06
2017-03-31 $0.34B $0.04B 8.56
2016-12-31 $0.37B $0.06B 6.64
2016-09-30 $0.36B $0.05B 6.67
2016-06-30 $0.18B $0.06B 3.29
2016-03-31 $0.17B $0.05B 3.45
2015-12-31 $0.19B $0.07B 2.93
2015-09-30 $0.19B $0.06B 3.27
2015-06-30 $0.20B $0.05B 3.87
2015-03-31 $0.21B $0.05B 4.34
2014-12-31 $0.21B $0.04B 4.70
2014-09-30 $0.21B $0.05B 4.33
2014-06-30 $0.23B $0.07B 3.26
2014-03-31 $0.20B $0.04B 4.64
2013-12-31 $0.20B $0.04B 4.68
2013-09-30 $0.20B $0.05B 4.14
2013-06-30 $0.20B $0.03B 5.82
2013-03-31 $0.20B $0.04B 4.53
2012-12-31 $0.11B $0.05B 2.28
2012-09-30 $0.11B $0.05B 2.32
2012-06-30 $0.12B $0.04B 2.70
2012-03-31 $0.13B $0.03B 3.94
2011-12-31 $0.13B $0.03B 4.74
2011-09-30 $0.14B $0.03B 5.57
2011-06-30 $0.15B $0.03B 5.56
2011-03-31 $0.13B $0.02B 7.95
2010-12-31 $0.14B $0.02B 7.52
2010-09-30 $0.13B $0.02B 6.52
2010-06-30 $0.15B $0.02B 6.13
2010-03-31 $0.14B $0.02B 7.93
2009-12-31 $0.15B $0.02B 7.79
2009-09-30 $0.10B $0.02B 5.48
2009-06-30 $0.08B $0.02B 4.79
2009-03-31 $0.10B $0.02B 5.05
2008-12-31 $0.09B $0.02B 5.22
2008-09-30 $0.11B $0.02B 6.70
2008-06-30 $0.13B $0.02B 8.04
2008-03-31 $0.09B $0.03B 3.49
2007-12-31 $0.11B $0.02B 5.17
2007-09-30 $0.11B $0.02B 5.90
2007-06-30 $0.13B $0.02B 7.50
2007-03-31 $0.03B $0.04B 0.67
2006-12-31 $0.04B $0.04B 1.02
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
2006-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $8.923B $0.564B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.825B 27.79
Medtronic (MDT) Ireland $147.584B 20.72
Stryker (SYK) United States $82.482B 28.52
Boston Scientific (BSX) United States $59.759B 28.99
Baxter (BAX) United States $44.643B 27.07
EssilorLuxottica Societe Anonyme (ESLOY) France $31.425B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.623B 18.32
Coloplast (CLPBY) Denmark $25.682B 41.00
Lonza Group Ag (LZAGY) Switzerland $25.628B 0.00
Terumo (TRUMY) Japan $22.710B 26.11
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
ResMed (RMD) United States $19.048B 36.32
Sunny Optical Technology (SNPTF) China $16.288B 0.00
Bio-Rad Laboratories (BIO) United States $10.082B 54.05
Canopy Growth (CGC) Canada $10.015B 0.00
Perrigo (PRGO) Ireland $7.527B 13.86
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.973B 20.79
Haemonetics (HAE) United States $6.488B 48.96
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.192B 0.00
Neogen (NEOG) United States $4.086B 67.83
NuVasive (NUVA) United States $3.383B 26.97
ICU Medical (ICUI) United States $3.322B 21.55
Hutchison China MediTech (HCM) China $2.766B 0.00
Quidel (QDEL) United States $2.645B 26.26
Agios Pharmaceuticals (AGIO) United States $2.144B 0.00
National Vision Holdings (EYE) United States $2.086B 45.03
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.577B 0.00
VAREX IMAGING (VREX) United States $1.099B 25.32
AtriCure (ATRC) United States $1.000B 0.00
Lantheus Holdings (LNTH) United States $0.999B 26.25
Omeros (OMER) United States $0.912B 0.00
Phibro Animal Health (PAHC) United States $0.882B 14.34
NanoString Technologies (NSTG) United States $0.807B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.793B 20.22
Cerus (CERS) United States $0.744B 0.00
PetIQ (PETQ) United States $0.740B 17.47
LeMaitre Vascular (LMAT) United States $0.710B 42.09
MacroGenics (MGNX) United States $0.631B 0.00
Surmodics (SRDX) United States $0.623B 118.46
TG Therapeutics (TGTX) United States $0.609B 0.00
Quanterix (QTRX) United States $0.598B 0.00
OraSure Technologies (OSUR) United States $0.463B 21.43
Meridian Bioscience (VIVO) United States $0.413B 12.88
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.373B 0.00
Utah Medical Products (UTMD) United States $0.371B 27.17
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.304B 32.28
United Health Products (UEEC) United States $0.293B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Rockwell Medical (RMTI) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.174B 0.00
Vapotherm (VAPO) United States $0.171B 0.00
Chimerix (CMRX) United States $0.146B 0.00
Fonar (FONR) United States $0.143B 10.19
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
InfuSystems Holdings (INFU) United States $0.102B 0.00
United-Guardian (UG) United States $0.088B 20.88
MRI Interventions (MRIC) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00